CelecoxibThird Party Manufacturing in India

Celecoxib belongs to the class of selective cyclooxygenase-2 inhibitors, commonly known as coxibs. Unlike traditional nonsteroidal anti-inflammatory drugs that inhibit both COX-1 and COX-2 enzymes, Celecoxib selectively targets COX-2. The cyclooxygenase enzymes are responsible for converting arachidonic acid into prostaglandins, which mediate inflammation, pain, and fever. COX-1 is constitutively expressed in most tissues and produces prostaglandins that protect the gastric mucosa, support platelet function, and maintain renal blood flow. COX-2, on the other hand, is induced primarily at sites of inflammation in response to cytokines, growth factors, and other inflammatory stimuli.

By selectively inhibiting COX-2, Celecoxib blocks the production of pro-inflammatory prostaglandins at the site of inflammation while sparing the COX-1-derived prostaglandins that protect the stomach lining. This selectivity gives Celecoxib a significant safety advantage over non-selective NSAIDs, resulting in a lower risk of gastrointestinal ulceration and bleeding. The drug is at least ten to twenty times more selective for COX-2 than COX-1 at therapeutic concentrations. Beyond its anti-inflammatory and analgesic effects, Celecoxib has demonstrated antiproliferative properties and is being studied for its potential role in cancer prevention, particularly in colorectal cancer where COX-2 overexpression is linked to tumor progression.

Therapeutic Uses

Celecoxib is prescribed for the management of:

• Osteoarthritis: Provides effective relief of joint pain, stiffness, and inflammation associated with osteoarthritis of the knee, hip, and hand.
• Rheumatoid Arthritis: Reduces joint swelling, pain, and morning stiffness in adult patients with rheumatoid arthritis.
• Ankylosing Spondylitis: Alleviates spinal inflammation and pain in patients with this chronic inflammatory condition.
• Acute Pain: Used for short-term management of acute pain conditions including dental pain, postoperative pain, and musculoskeletal injuries.
• Primary Dysmenorrhea: Effective for the relief of menstrual cramping and pain.
• Familial Adenomatous Polyposis: Used to reduce the number of precancerous colorectal polyps in patients with FAP.

Why Manufacturers Choose Celecoxib

Celecoxib is the most widely prescribed COX-2 selective NSAID globally and holds a substantial share of the analgesic market. Its favorable gastrointestinal safety profile compared to traditional NSAIDs makes it a preferred choice for patients requiring long-term pain management, particularly in the aging population. Indian manufacturers produce Celecoxib in 50mg, 100mg, 200mg, and 400mg tablet strengths, covering the full therapeutic range. The molecule has strong demand from both domestic PCD franchise networks and export markets, especially in regions with a high prevalence of arthritis and chronic pain conditions. WHO-GMP certified production ensures access to regulated markets including the US, UK, and EU.